0001062993-23-005069.txt : 20230228
0001062993-23-005069.hdr.sgml : 20230228
20230228123801
ACCESSION NUMBER: 0001062993-23-005069
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230224
FILED AS OF DATE: 20230228
DATE AS OF CHANGE: 20230228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Renaudin George II
CENTRAL INDEX KEY: 0001964078
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-05975
FILM NUMBER: 23682121
MAIL ADDRESS:
STREET 1: 500 W. MAIN SREET
CITY: LOUISVILLE
STATE: KY
ZIP: 40202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HUMANA INC
CENTRAL INDEX KEY: 0000049071
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
IRS NUMBER: 610647538
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 W MAIN ST
CITY: LOUISVILLE
STATE: KY
ZIP: 40202
BUSINESS PHONE: 5025801000
MAIL ADDRESS:
STREET 1: 500 W. MAIN ST
CITY: LOUISVILLE
STATE: KY
ZIP: 40202
FORMER COMPANY:
FORMER CONFORMED NAME: EXTENDICARE INC
DATE OF NAME CHANGE: 19740404
FORMER COMPANY:
FORMER CONFORMED NAME: HERITAGE HOUSE OF AMERICA INC
DATE OF NAME CHANGE: 19671129
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2023-02-24
0000049071
HUMANA INC
HUM
0001964078
Renaudin George II
HUMANA INC.
500 W. MAIN STREET
LOUISVILLE
KY
40202
0
1
0
0
President, Medicare & Medicaid
Humana Common
2023-02-24
4
M
0
1393
0
A
1393
D
Humana Common
2023-02-24
4
F
0
347
510.2425
D
1046
D
Humana Common
474
I
See Footnote
Options
510.2425
2023-02-24
4
A
0
4162
0
A
2030-02-24
Humana Common
4162
4162
D
Restricted Stock Units
Humana Common
241
241
D
Restricted Stock Units
Humana Common
1241
1241
D
Restricted Stock Units
Humana Common
459
459
D
Restricted Stock Units
Humana Common
609
609
D
Restricted Stock Units
2023-02-24
4
A
0
1078
0
A
Humana Common
1078
1078
D
Phantom Stock Units
Humana Common
148
148
I
See Footnote
Shares held for the benefit of reporting person as of January 31, 2023 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c).
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.
Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
Restricted stock units granted to reporting person on 2/22/2021, 33% of the award is vesting on 12/15/21, 12/15/22, and 12/15/23.
Restricted stock units granted to reporting person on 9/1/2021, 100% of the award is vesting on 9/1/2024.
Restricted stock units granted to reporting person on 2/21/2022, 33% of the award is vesting on 12/15/22, 12/15/23, and 12/15/24.
Restricted stock units granted to reporting person on 10/1/2022, 100% of the award is vesting on 10/1/2025.
Restricted stock units granted to reporting person on 2/24/2023, 33% of the award is vesting on 12/15/23, 12/15/24, and 12/15/25.
Phantom Stock Units held for the benefit of reporting person as of January 31, 2023 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. The ending number of units reflects normal fluctuation due to changes in stock price.
Performance Stock Units vested on 2/24/23, not required to be reported until vest.
Disposition reported represents shares withheld for payment of tax liability associated with vesting of Performance Stock Units on 2/24/23.
George Renaudin II
2023-02-28